Global Molecular Diagnostics Market, 2020-2026

The global molecular diagnostics market size was valued at $12,134.69 million in 2019 and is projected to reach $21,716.83 million by 2026, registering a CAGR of 8.67% from 2020 to 2026. The molecular diagnostics market is segmented on the basis of product, technology, application, and region. The report offers a breakdown of market shares by product, including Instruments, Kits & Reagents. Based on technology, the market for molecular diagnostics is segmented into Polymerase Chain Reaction (PCR), Microarrays, In Situ Hybridization (ISH), Next generation Sequencing (NGS), Others. By application, the molecular diagnostics market is classified into Hospitals & Clinics, Diagnostic Centers, Research Institutes. On the basis of region, the molecular diagnostics industry is analyzed across North America, Europe, Asia Pacific, South America and MEA (the Middle East, and Africa). By Product: Instruments Kits & Reagents By Technology: Polymerase Chain Reaction (PCR) Microarrays In Situ Hybridization (ISH) Next generation Sequencing (NGS) Others By Application: Hospitals & Clinics Diagnostic Centers Research Institutes By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026. North America (U.S., Canada, Mexico, etc.) Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.) Europe (Germany, UK, France, Italy, Russia, Spain, etc.) Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.) South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.) The market research report covers the analysis of key stake holders of the molecular diagnostics market. Some of the leading players profiled in the report include: Abbott Laboratories Agilent Technologies, Inc. Becton, Dickinson and Company bioMérieux S.A. Bio Rad Laboratories, Inc. Danaher Corporation F. Hoffmann La Roche AG Hologic, Inc. Illumina, Inc. QIAGEN N.V. Siemens AG Thermo Fisher Scientific, Inc. *list is not exhaustive, request free sample to get a complete list of companies The base year of the study is 2019, and forecasts run up to 2026. Research Objective To analyze and forecast the market size of global molecular diagnostics market. To classify and forecast global molecular diagnostics market based on product, technology, application, and region. To identify drivers and challenges for global molecular diagnostics market. To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global molecular diagnostics market. To conduct pricing analysis for global molecular diagnostics market. To identify and analyze the profile of leading players operating in global molecular diagnostics market. The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are: Manufacturers of molecular diagnostics Raw material suppliers Market research and consulting firms Government bodies such as regulating authorities and policy makers Organizations, forums and alliances related to molecular diagnostics